Are you interested in joining the ECTS-Mellanby Training Course, but you are not registered to ECTS 2020?

The Training Course is open to all ECTS 2020 Digital Congress Delegates, however, a separate registration fee is also available.  if you are not an ECTS 2020 Digital Congress delegate, you can still join the course at a special registration rate of 50€ (incl. VAT) and access the full course material, live networking and discussions.

Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

  • understand the process of bone remodelling and how this can be studied using BTM
  • appreciate the methods used for measuring BTM and their sources of variability
  • be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP
  • be familiar with best practice in the clinical use of BTM

 

ECTS@HOME PROGRAMME

Online Training Course – Tuesday 17 November 2020

Training Co-Chairs: Richard Eastell, Sheffield, UK; Pawel Szulc, Lyon, France

 

Pre-Recorded Presentations

BONE TURNOVER MARKERS: AN INTRODUCTIONRichard Eastell (Sheffield, UK)
BONE REMODELLING AND THE INTERPRETATION OF BONE TURNOVER MARKER (BTM) RESULTS Richard Eastell (Sheffield, UK)
PRACTICAL ASPECTS OF MEASUREMENT AND SELECTION OF MARKERPawel Szulc (Lyon, France)
SOURCES OF VARIABILITY IN BTM Nuria Guanabens (Barcelona, Spain)
USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE Jennie Walsh (Sheffield, UK)
METABOLIC BONE DISEASES IN ADULTS Eugene McCloskey (Sheffield, UK)
METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDER Barbara Obermayer-Pietsch (Graz, Austria)

Live and Interactive Sessions

14.30 – 15.30Interactive Workshops GROUP A & GROUP B
GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Nuria Guanabens (Barcelona, Spain)
GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION
 Richard Eastell (Sheffield, UK), Pawel Szulc (Lyon, France)
15.30 – 15.40Break
15.40 - 16.40Interactive Workshops GROUP A & GROUP B
GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Nuria Guanabens (Barcelona, Spain) 
GROUP C: USING BTM IN METABOLIC BONE DISEASE
Eugene McCloskey (Sheffield, UK) Jaja Salam (Sheffield, UK) 
16.40 – 17.30EXPERT PANEL: QUESTIONS AND ANSWERS All speakers